{
}
Goldman Sachs analyst Adam Hotchkiss maintains a Buy rating on Waystar Holding Corp. (NASDAQ: WAY) with a price target of $52, despite a 14% stock decline since Q4 earnings. Concerns over modest FY25 revenue growth and the sustainability of FY24 tailwinds are noted, though a bull scenario suggests low double-digit growth could exceed management's ~7% guidance. Key factors for growth include stable gross retention and strong RFP activity from healthcare systems.
Goldman Sachs analyst Adam Hotchkiss maintains a Buy rating on Waystar Holding Corp, despite a 14% stock decline since Q4 earnings, attributed to modest FY25 revenue guidance. Concerns linger over the sustainability of FY24 growth drivers, while potential for low double-digit growth in FY25 hinges on strong RFP activity and cash flow improvements.
Director Paul G. Moskowitz sold 5,652,689 shares of Waystar Holding Corp. at an average price of $38.60, resulting in a total value of $218.2 million and a 20.20% decrease in his ownership. Following the sale, he retains 22,327,728 shares valued at $861.9 million. In the last three months, insiders have sold 13,356,171 shares worth $526.7 million. Charles Schwab Investment Management Inc. increased its stake in Waystar by 3.0%, owning 377,710 shares valued at $13.9 million. Analysts maintain a "Buy" rating for Waystar, with price targets ranging from $40 to $52.
Deutsche Bank has raised its price target for Waystar Holding Corp. to $45 from $34 while maintaining a Buy rating. Waystar provides essential cloud software for healthcare organizations, automating payment workflows and enhancing billing accuracy through advanced AI and algorithms, benefiting a wide range of healthcare providers.
The Healthcare Prior Authorization Software Market is set for significant growth from 2024 to 2031, driven by emerging trends and opportunities. A comprehensive analysis highlights key players, market dynamics, and segmentation, providing insights for stakeholders to enhance competitiveness and identify new business avenues. The report emphasizes the importance of understanding market drivers, challenges, and customer preferences to formulate effective strategies.
Doximity reported adjusted earnings of 30 cents per share, surpassing forecasts, with a 17% revenue increase and a 36% rise in net income for the first half of the fiscal year. The company expects Q3 revenue between $152 million and $153 million and has raised its 2024 revenue guidance to $535-$540 million.Waystar also exceeded expectations with Q3 revenue of $240 million, a 22% year-over-year increase, and raised its 2024 outlook to $926-$934 million. The company is leveraging AI-driven automation to enhance its healthcare payment solutions, benefiting from a surge in new clients following a competitor's cyberattack.
The Patient Payment Solutions in Healthcare Market is poised for significant growth from 2024 to 2031, driven by evolving consumer behaviors and technological advancements. Key players include Waystar, Zocdoc, and PayPal, with a competitive landscape characterized by new product launches and strategic collaborations. The report provides in-depth analysis, including market segmentation, regional insights, and a comprehensive overview of industry dynamics.
Waystar Holding Corp.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
waystar faces growth challenges as analyst maintains buy rating and price forecast
18:49 25.03.2025
Waystar faces growth challenges despite strong 2024 performance and analyst support
18:49 25.03.2025
waystar director sells shares amid insider trading activity and analyst upgrades
08:10 22.03.2025
deutsche bank raises waystar price target to forty five dollars
13:48 26.02.2025
healthcare prior authorization software market poised for significant growth by 2031
Waystar Holding Corp.
Experian
Change Healthcare Inc.
Donald Trump
Mr. Shah
Ravina Pandya
Experian Information Solutions
Show more
15:12 19.11.2024
health tech companies report strong earnings and raise future guidance
United States Dollar
Waystar Holding Corp.
Doximity, Inc.
Hims & Hers Health, Inc.
Andrew Dudum
Matt Hawkins
Jeff Tangney
Show more
17:00 15.11.2024
patient payment solutions market poised for growth from 2024 to 2031
Stripe
Waystar Holding Corp.
Square 1 Bank
Zocdoc
PayPal Holdings, Inc.
Patientco
FRA
RUS
GBR
COL
ITA
USA
KOR
NGA
SAU
JPN
MEX
ARE
ZAF
BRA
ARG
CHN
EGY
IND
DEU
CAN
Waystar
Stripe
Square
Zocdoc
Patientco
Show more
10:43 04.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Retail and Consumer Goods
Supply Chain Management
Stock Market Updates
Private Equity Deals
Government Economic Policies
Industry Mergers & Acquisitions
Fintech Startups
Energy Sector Developments
AI Applications
Funding Rounds & Investments
Venture Capital Investments
AI Innovations
Emerging Startups
Commodities
CEO Changes
Inflation and Monetary Impact
Countries:
Companies:
Apple Inc.
Google Inc.
Tesmec S.p.A.
Amazon.com, Inc.
Microsoft Corporation
Mastercard Inc
NVIDIA Corp
Tesla, Inc.
OpenAI ERC USD
The Goldman Sachs Group, Inc.
Visa Inc.
SWIGGY LIMITED
GLOE Inc.
Mistral 1
S&P 500
Ripple USD USD
NAURA Technology Group Co., Ltd.
OLA ELECTRIC MOBILITY LTD
Microsoft Corp
Micron Technology, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
United Arab Emirates Dirham
British Pound Sterling
Saudi Riyal
New Zealand Dollar
Qatari Riyal
Thai Baht
Vietnamese Đồng
Canadian Dollar
Indonesian Rupiah
South Korean Won
Malaysian Ringgit
Brazilian Real
Swiss Franc
Bangladeshi Taka
Kuwaiti Dinar
People: